These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 10866044)

  • 1. Effects of glucosamine infusion on insulin secretion and insulin action in humans.
    Monauni T; Zenti MG; Cretti A; Daniels MC; Targher G; Caruso B; Caputo M; McClain D; Del Prato S; Giaccari A; Muggeo M; Bonora E; Bonadonna RC
    Diabetes; 2000 Jun; 49(6):926-35. PubMed ID: 10866044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased hexosamine availability similarly impairs the action of insulin and IGF-1 on glucose disposal.
    Hawkins M; Barzilai N; Chen W; Angelov I; Hu M; Cohen P; Rossetti L
    Diabetes; 1996 Dec; 45(12):1734-43. PubMed ID: 8922359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucosamine-induced inhibition of liver glucokinase impairs the ability of hyperglycemia to suppress endogenous glucose production.
    Barzilai N; Hawkins M; Angelov I; Hu M; Rossetti L
    Diabetes; 1996 Oct; 45(10):1329-35. PubMed ID: 8826967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term glucosamine infusion does not affect insulin sensitivity in humans.
    Pouwels MJ; Jacobs JR; Span PN; Lutterman JA; Smits P; Tack CJ
    J Clin Endocrinol Metab; 2001 May; 86(5):2099-103. PubMed ID: 11344213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance in multiple insulin sensitive tissues.
    Virkamäki A; Daniels MC; Hämäläinen S; Utriainen T; McClain D; Yki-Järvinen H
    Endocrinology; 1997 Jun; 138(6):2501-7. PubMed ID: 9165041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes.
    Kashyap S; Belfort R; Gastaldelli A; Pratipanawatr T; Berria R; Pratipanawatr W; Bajaj M; Mandarino L; DeFronzo R; Cusi K
    Diabetes; 2003 Oct; 52(10):2461-74. PubMed ID: 14514628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucosamine infusion in rats mimics the beta-cell dysfunction of non-insulin-dependent diabetes mellitus.
    Shankar RR; Zhu JS; Baron AD
    Metabolism; 1998 May; 47(5):573-7. PubMed ID: 9591749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise-stimulated glucose turnover in the rat is impaired by glucosamine infusion.
    Miles PD; Higo K; Olefsky JM
    Diabetes; 2001 Jan; 50(1):139-42. PubMed ID: 11147779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo glucosamine infusion induces insulin resistance in normoglycemic but not in hyperglycemic conscious rats.
    Rossetti L; Hawkins M; Chen W; Gindi J; Barzilai N
    J Clin Invest; 1995 Jul; 96(1):132-40. PubMed ID: 7615783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Troglitazone prevents hyperglycemia-induced but not glucosamine-induced insulin resistance.
    Miles PD; Higo K; Romeo OM; Lee MK; Rafaat K; Olefsky JM
    Diabetes; 1998 Mar; 47(3):395-400. PubMed ID: 9519745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin secretion after short- and long-term low-grade free fatty acid infusion in men with increased risk of developing type 2 diabetes.
    Storgaard H; Jensen CB; Vaag AA; Vølund A; Madsbad S
    Metabolism; 2003 Jul; 52(7):885-94. PubMed ID: 12870166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo effects of glucosamine on insulin secretion and insulin sensitivity in the rat: possible relevance to the maladaptive responses to chronic hyperglycaemia.
    Giaccari A; Morviducci L; Zorretta D; Sbraccia P; Leonetti F; Caiola S; Buongiorno A; Bonadonna RC; Tamburrano G
    Diabetologia; 1995 May; 38(5):518-24. PubMed ID: 7489833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of norepinephrine on insulin secretion and glucose effectiveness in non-insulin-dependent diabetes.
    Walters JM; Ward GM; Barton J; Arackal R; Boston RC; Best JD; Alford FP
    Metabolism; 1997 Dec; 46(12):1448-53. PubMed ID: 9439541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discordant effects of glucosamine on insulin-stimulated glucose metabolism and phosphatidylinositol 3-kinase activity.
    Hawkins M; Hu M; Yu J; Eder H; Vuguin P; She L; Barzilai N; Leiser M; Backer JM; Rossetti L
    J Biol Chem; 1999 Oct; 274(44):31312-9. PubMed ID: 10531330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epinephrine exerts opposite effects on peripheral glucose disposal and glucose-stimulated insulin secretion. A stable label intravenous glucose tolerance test minimal model study.
    Avogaro A; Toffolo G; Valerio A; Cobelli C
    Diabetes; 1996 Oct; 45(10):1373-8. PubMed ID: 8826974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High glucose and glucosamine induce insulin resistance via different mechanisms in 3T3-L1 adipocytes.
    Nelson BA; Robinson KA; Buse MG
    Diabetes; 2000 Jun; 49(6):981-91. PubMed ID: 10866051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin and glucosamine infusions increase O-linked N-acetyl-glucosamine in skeletal muscle proteins in vivo.
    Yki-Järvinen H; Virkamäki A; Daniels MC; McClain D; Gottschalk WK
    Metabolism; 1998 Apr; 47(4):449-55. PubMed ID: 9550544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiologic modeling of the intravenous glucose tolerance test in type 2 diabetes: a new approach to the insulin compartment.
    Ward GM; Walters JM; Barton J; Alford FP; Boston RC
    Metabolism; 2001 May; 50(5):512-9. PubMed ID: 11319711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients.
    Henriksen JE; Levin K; Thye-Rønn P; Alford F; Hother-Nielsen O; Holst JJ; Beck-Nielsen H
    Diabetes; 2000 Jul; 49(7):1209-18. PubMed ID: 10909980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation.
    Carpentier A; Mittelman SD; Lamarche B; Bergman RN; Giacca A; Lewis GF
    Am J Physiol; 1999 Jun; 276(6):E1055-66. PubMed ID: 10362618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.